Revelation Biosciences Inc (REVB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,612 | -136 | -9 | -8 | -7 |
| Depreciation Amortization | 1 | 0 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 219 | N/A | N/A | N/A | N/A |
| Other Working Capital | 117 | -84 | N/A | N/A | 22 |
| Other Operating Activity | -106 | 2 | 0 | 0 | 0 |
| Operating Cash Flow | $-2,382 | $-219 | $-9 | $-8 | $15 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | -527 | N/A | N/A | N/A |
| PPE Investments | -99 | 0 | N/A | N/A | N/A |
| Purchase Of Investment | N/A | -73,509 | N/A | N/A | N/A |
| Other Investing Activity | 0 | -2 | 0 | 0 | 0 |
| Investing Cash Flow | $-99 | $-74,038 | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | 290 | 290 | 78 | 50 |
| Common Stock Issued | 600 | 74,559 | 3,150 | N/A | N/A |
| Other Financing Activity | 7,405 | -581 | -110 | -70 | -65 |
| Financing Cash Flow | $8,005 | $74,268 | $3,330 | $8 | $-15 |
| Beginning Cash Position | 4,492 | 0 | N/A | N/A | N/A |
| End Cash Position | 10,016 | 12 | 3,321 | N/A | N/A |
| Net Cash Flow | $5,524 | $12 | $3,321 | $N/A | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,382 | -219 | -9 | -8 | 15 |
| Capital Expenditure | -99 | N/A | N/A | N/A | N/A |
| Free Cash Flow | -2,481 | -219 | -9 | -8 | 15 |